⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16647719 | 0.81 | — | — | |
| SCHEMBL18849626 | 0.81 | — | — | |
| SCHEMBL633324 | 0.76 | — | — | |
| SCHEMBL31352548 | 0.76 | — | — | |
| SCHEMBL15508385 | 0.76 | — | — | |
| SCHEMBL491883 | 0.76 | — | — | |
| SCHEMBL3497544 | 0.76 | — | — | |
| SCHEMBL4204733 | 0.76 | — | — | |
| SCHEMBL92625 | 0.76 | — | — | |
| SCHEMBL6182662 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101924-A1 | KRAS MODULATORS | ALTEROME THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |